Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Drini, Musa ^a,b   Wong, Nicholas C ^a   Scott, Hamish S ^c   Craig, Jeffrey M ^a   Dobrovic, Alexander ^a,d   Hewitt, Chelsee A ^d   Dow, Christofer ^e   Young, Joanne P ^f   Jenkins, Mark A ^a   Saffery, Richard ^a   Macrae, Finlay A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GENE PRODUCT; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN DNMT3L; PROTEIN MLH1; PROTEIN WIF1; THYMINE; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLON POLYPOSIS; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENETIC CORRELATION; GENETIC SCREENING; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASTIC POLYPOSIS SYNDROME; INTRON; MALE; MUTATIONAL ANALYSIS; POPULATION GENETICS; PROMOTER REGION; SEQUENCE ANALYSIS; COLORECTAL TUMOR; CPG ISLAND; DNA DENATURATION; ENZYMOLOGY; EXON; GASTROINTESTINAL POLYPOSIS; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; MUTATION; TRANSITION TEMPERATURE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; FEMALE; HUMANS; INTESTINAL POLYPOSIS; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID DENATURATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TRANSITION TEMPERATURE;

EID: 79951818061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016831     Document Type: Article

References (66)

1. Burt R, Jass JR, (2000) Hyperplastic Polyposis In: Hamilton SR, Aaltonen LA, editors. Pathology and Genetics of Tumours of Digestive System Lyon IARC Press pp. 135-136.
2. Jass JR, (2000) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2 (8): 398-405.
3. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP, (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124 (3): 380-91.
4. Goldstein NS, (2006) Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 125 (1): 146-53.
5. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (7): 787-93.
6. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, et al. (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55 (10): 1467-74.
7. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, et al. (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (8): 1137-44.
8. Chan TL, Zhao W, Leung SY, Yuen ST, (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63 (16): 4878-81.
9. Kondo Y, Issa JP, (2004) Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 23 (1-2): 29-39.
10. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B, (2002) Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51 (6): 797-802.
11. Toyota M, Ohe-Toyota M, Ahuja N, Issa JP, (2000) Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci 97 (2): 710-5.
12. Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, et al. (2004) Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22 (22): 4584-94.
13. O'Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, et al. (2004) Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28 (4): 423-34.
14. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A, (2002) Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160 (2): 529-36.
15. Issa JP, Shen L, Toyota M, (2005) CIMP, at last. Gastroenterology 129 (3): 1121-4.
16. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genetics 3 (6): 415-428.
17. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, et al. (2006) Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genetics 38 (5): 540-549.
18. Bestor TH, (1998) GAMETOGENESIS '98: Methylation and the Unequal Developmental Potentials of the Oocyte and Sperm Genomes. Am J Hum Genet 62: 1269-1273.
19. Okano M, Xie S, Li E, (1998) Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acid Research 26: 2536-2540.
20. Okano M, Bell DW, Haber DA, Li E, (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (3): 247-57.
21. Xie S, Wang Z, Okano M, Nogami M, Li Y, et al. (1999) Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 236 (1): 87-95.
22. Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, et al. (2000) Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 65 (3): 293-8.
23. Webster K, O'Bryan MK, Fletcher S, Crewther PE, Aapola U, et al. (2005) Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. PNAS 102 (11): 4068-4073.
24. Gruenbaum Y, Cedar H, Razin A, (1982) Substrate and sequence specificity of a eukariotic DNA methylase. Nature 295: 620-22.
25. Flynn J, Glickman JF, Reich NO, (1996) Murine DNA cytosine-C5 methyltransferase: pre-steady- and steady-state kinetic analysis with regulatory DNA sequences. Biochemistry 35 (23): 7308-15.
26. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, et al. (2004) Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429 (6994): 900-3.
27. Dodge JE, Okano M, Dick F, Tsujimoto N, Chen T, et al. (2005) Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 280 (18): 17986-91.
28. Aapola U, Lyle R, Krohn K, Antonarakis SE, Peterson P, (2001)- Isolation and initial characterization of the mouse Dnmt3l gene.- Cytogenet Cell Genet 92 (1-2): 122-6.
29. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X, (2007) Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449 (7159): 248-51.
30. Kanai Y, Hirohashi S, (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28 (12): 2434-42.
31. Issa JP, (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4 (12): 988-93.
32. Nosho K, Shima K, Irahara N, Kure S, Baba Y, et al. (2009) DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 15 (11): 3663-71.
33. Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, et al. (2010) Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplasia progression. Gut 223602 Published Online.
34. Sjobolm T, Jones S, Wood LD, (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
35. Steger G, (1994) Thermal denaturation of double-stranded nucleic acids: prediction of temperatures critical for gradient gel electrophoresis and polymerase chain reaction. Nucleic Acid Research 22 (14): 2760-2768.
36. Krypuy M, Newnham GM, Thomsa DM, Conron M, Dobrovic A, (2006) High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer 6 (295).
37. Ehrich M, Correll D, van den Boom D, (2006) Introduction to EpiTYPER for Quantitative DNA Methylation Analysis Using the MassARRAY System. Sequenome.
38. Wong N, Morley R, Saffery R, Craig J, (2008) Archived Guthrie blood spots as a novel source for quantitative DNA methylation analysis. Biotechniques 45 (4): 423-4.
39. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, et al. (2005) BiQ Analyzer: vizualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21 (21): 4067-4068.
40. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ, (2004) BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28 (11): 1452-9.
41. Roll JD, Rivenbark AG, Jones WD, Coleman WB, (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 7: 15.
42. Jin B, Tao Q, Peng J, Soo HM, Wu W, et al. (2008) DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet 17 (5): 690-709.
43. Minoo P, Moyer M, Jass J, (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212 (2): 124-133.
44. Carvajal-Carmona L, Howarth K, Lockett M, Polanco-Echeverry G, Volikos E, et al. (2007) Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol 212: 378-385.
45. Park B, Kim LH, Shin HD, Park YW, Uhm WS, et al. (2004) Association analysis of DNA methyltransferase-1 (DNMT1) polymorphism with systemic lupus erythematosus. J Hum Genet 49 (11): 642-6.
46. Hansen RS, Wijimenga C, Luo P, Stanek AM, Canfield CM, et al. (1999) The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci 96 (25): 14412-14417.
47. Kelmen LE, Sellers TA, Schildkraut JM, Cuningham JM, Vierkant RA, et al. (2008) Genetic variations in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 68 (7): 2498-506.
48. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, et al. (2006) Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27 (8): 1661-9.
49. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, et al. (2005) DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26 (2): 403-9.
50. Montgomery KG, Liu MC, Eccles DM, Campbell IG, (2004) The DNMT3B C-T promoter polymorphism and risk of breast cancer in a british population: a case-control study. Breast cancer Reasearch 6: R390-R394.
51. El-Maarri O, Kareta MS, Mikeska T, Becker T, Diaz-Lacava A, et al. (2009) A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum Mol Genet 26: 26.
52. Perta M, Lin X, Salzberg SL, (2001) GeneSplicer: a new computational method for splice site prediction. Nucleic Acid Res 29 (5): 1185-90.
53. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, et al. (2009) Genoma-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41 (9): 986-90.
54. Hindorff L, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human disease and traits. Proc Natl Acad Sci 106 (23): 9362-7.
55. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, et al. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci 95 (12): 6870-5.
56. Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Sugimura T, et al. (1996) Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesi. Japanese journal of cancer research 87 (12): 1210-1217.
57. Ushijima T, Watanabe N, Shimizu K, Miyamoto K, Sugimura T, et al. (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5 (3): 223-231.
58. Kato Y, Kaneda M, Hata K, Kumaki K, Hisano M, et al. (2007) Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. Hum Mol Genet 16 (19): 2272-80.
59. Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH, (2001) Dnmt3L and the establishment of maternal genomic imprints. Science 294: 2536-2539.
60. Gokul G, Gautami B, Malathi S, Sowjanya AP, Polli UR, et al. (2007) DNA Methylation Profile at the DNMT3L Promoter: A Potential Biomarker for Cervical Cancer. Epigenetics 2 (2): 80-85.
61. Gokul G, Ramakrishna G, Khosla S, (2009) Reprogramin of HeLa cells upon DNMT3L overexpression mimics carcinogenesis. Epigenetics 4 (5): 322-9.
62. Boss JL, (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297.
63. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, et al. (1999) Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 52 (6): 455-60.
64. Benhattar J, Losi L, Chaubert P, Givel JC, Costa L, (1993) Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104 (327): 293-297.
65. Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, et al. (2007) Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213.
66. Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, et al. (2006) Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131 (1): 30-9.